The stethoscope comes up at a routine exam. Everything else about the appointment was unremarkable. Then the veterinarian pauses, listens again, and tells you there’s a murmur. Your dog has no idea anything significant just happened. You leave with a follow-up appointment and more questions than answers.
That moment is one of the most common sources of anxiety in small animal veterinary care, and the fear is understandable. But a murmur on its own isn’t a diagnosis. It’s a signal, and what that signal means depends on context: what’s causing it, how loud it is, and crucially, whether anything is changing. Answering those questions requires more than a single exam can provide.
CompanAIn was built for exactly this kind of longitudinal challenge. By consolidating every murmur grade ever recorded, every cardiac lab result, and every owner observation into a continuously evolving Living Health Timeline, CompanAIn’s agentic AI gives veterinarians the documented history to evaluate whether a murmur is stable, progressing, or reaching a threshold that calls for intervention.
What a Heart Murmur Is
The heart is designed as a one-way system. Blood moves through four chambers in a precise sequence, guided by valves that open and close with each beat. A murmur is the additional whooshing or swishing noise produced when blood flow becomes turbulent, typically because a valve isn’t opening or closing cleanly, or because blood is finding a path it wasn’t meant to take.
Not every murmur reflects serious disease. Puppies commonly develop innocent or physiologic murmurs from rapid growth rather than structural problems. Research has found that roughly 20% of young puppies have an innocent murmur at an early checkup, and most resolve on their own by five to six months of age. These carry no impact on health or lifespan.
The murmurs that require attention are pathologic ones caused by underlying structural changes to the heart itself, which warrant grading, monitoring, and, in many cases, a formal cardiology workup.
The Grading Scale: What Each Level Means
Veterinarians grade murmurs on a scale of 1 to 6, rating loudness as a proxy for the degree of turbulence and likely disease severity. The system isn’t perfect, but it provides a consistent framework for monitoring over time.
- Grade 1 is barely audible, detectable only in a quiet room in one specific location
- Grade 2 is soft but consistently heard with a stethoscope
- Grade 3 is moderate in volume, heard clearly on one side of the chest, and is typically the threshold for further diagnostics
- Grade 4 is loud and audible on both sides of the chest
- Grade 5 is very loud with a palpable vibration felt through the chest wall
- Grade 6 is the most severe, audible with the stethoscope held slightly away from the chest
Grades 1 and 2 warrant monitoring but don’t always require immediate workup. Grade 3 and above generally calls for chest radiographs and, ideally, an echocardiogram. Trajectory matters as much as current grade. A murmur that was Grade 2 last year and is now Grade 4 tells a very different story than one stable at Grade 3 for three years.
What AI-Assisted Grading Changes
Murmur grading has a well-documented reliability problem. The 1-6 scale depends on clinical expertise and the conditions of a single exam, and research published in the Journal of Veterinary Internal Medicine notes that grading carries significant interobserver variability that limits its diagnostic utility. Two veterinarians listening to the same dog can arrive at different grades, and the same veterinarian can grade the same murmur differently across visits depending on positioning, ambient noise, and equipment.
That variability matters most when the grade itself is what triggers a treatment decision. The difference between Stage B1 and B2 MMVD determines whether pimobendan is indicated. Getting that staging wrong in either direction has real consequences.
Machine Learning Applied to Heart Sound Analysis
Researchers at the University of Cambridge developed a machine learning algorithm trained on electronic stethoscope recordings from 756 dogs to detect and grade murmurs with a sensitivity of 87.9%, matching expert cardiologist assessment. The algorithm demonstrated particular strength in distinguishing between Stage B1 and B2 preclinical MMVD, achieving an area under the curve of 0.861 for that distinction specifically.
The clinical implication is significant. Murmur grading in primary care settings is constrained by time, equipment, and the variability of human auscultation. An algorithm that analyzes the acoustic properties of a heart sound objectively, free from the inconsistencies of exam-room conditions, adds a layer of precision that improves how reliably the B2 threshold can be identified.
The Most Common Underlying Causes
Myxomatous Mitral Valve Disease
Myxomatous mitral valve disease (MMVD) is the leading cause of cardiovascular disease in dogs, accounting for the majority of acquired murmurs in small breeds. The mitral valve gradually thickens and degenerates, causing blood to leak backward with each heartbeat and placing an increasing volume load on the left heart. Cavalier King Charles Spaniels, Dachshunds, and Miniature Schnauzers are among the most predisposed breeds.
MMVD progresses through defined stages. The reason Stage B2 matters specifically comes down to a landmark trial. The EPIC study, published in the Journal of Veterinary Internal Medicine, enrolled 360 dogs with preclinical MMVD and cardiac enlargement. Dogs treated with pimobendan before developing congestive heart failure remained in the preclinical stage an average of 15 months longer than dogs receiving a placebo. Identifying a dog at Stage B2, before symptoms develop, is the treatment window that changes outcomes.
Dilated Cardiomyopathy
Dilated cardiomyopathy (DCM) weakens the heart muscle and enlarges the chambers, reducing pumping efficiency. It is more common in large breeds including Doberman Pinschers, Great Danes, and Irish Wolfhounds. Murmurs associated with DCM may be softer and more variable. Affected dogs can deteriorate quickly, making consistent documented cardiac history particularly important for timely management.
Life Expectancy: What the Evidence Says
There is no single answer without context. Dogs with innocent murmurs have an entirely normal life expectancy. Dogs with low-grade MMVD detected early and monitored appropriately can live years without symptoms, especially when treatment begins at the right stage. Dogs with DCM or advanced congestive heart failure face more limited timelines, though modern cardiac medications have meaningfully extended quality of life even in these cases.
What the research makes clear is that timing matters enormously. The EPIC trial showed that dogs at Stage B2 who received pimobendan had roughly 60% longer preclinical periods. Identifying when a dog has reached that treatment window requires knowing they’ve reached it, which requires consistent documented cardiac monitoring over time.
Monitoring Protocols: What Should Happen and When
Any newly detected murmur should be graded and recorded precisely. Grade 3 and above warrants chest radiography and echocardiography when accessible, particularly in predisposed breeds. Recheck intervals depend on grade and stability, ranging from every 6 to 12 months for stable low-grade murmurs to more frequent evaluation for higher grades with cardiac enlargement.
At home, owners of dogs with known cardiac disease can monitor resting respiratory rate as a practical early warning tool. A resting rate consistently above 30 breaths per minute in a sleeping dog can indicate early fluid accumulation before other symptoms become obvious. Count breaths for 30 seconds and double the result, ideally at the same time each day to build a reliable baseline. Any sustained increase from the dog’s established baseline warrants a same-day call to the veterinarian.
Other changes worth documenting include reduced willingness to exercise, a new or worsening cough, restlessness at night, reduced appetite, or any episodes of weakness or brief collapse. These can be early signs of decompensating heart disease and are exactly the kind of observations that become medically meaningful when they’re recorded rather than recalled from memory.
How CompanAIn's Agentic AI Supports Cardiac Monitoring
The clinical window for starting pimobendan in Stage B2 MMVD is defined by measurable echocardiographic thresholds. Reaching that window undetected, because consecutive findings were never compared systematically, is a failure of continuity rather than veterinary skill. CompanAIn’s agentic AI addresses that problem directly.
Tracking the Trajectory That Defines the Treatment Window
When echocardiogram reports, chest radiograph findings, murmur grades, and resting respiratory rate logs are uploaded through Smart Upload, the Living Health Timeline places each data point in relationship to every other. A murmur graded at 2 in year one and 3 in year two, alongside a radiograph showing early cardiomegaly, generates a pattern that tells a very different story than any single finding reviewed alone.
CompanAIn’s Trend Detection marks cardiac findings as improving, stable, concerning, or declining across uploaded data points.
For MMVD specifically, this means:
- Gradual left atrial enlargement across successive echocardiograms
- A resting respiratory rate climbing from 22 to 26 to 29 over three months
- A murmur grade that has moved twice in two years
All of these can generate proactive alerts before a dog is visibly symptomatic, at the stage when pimobendan still has a treatment window to protect.
Keeping the Full Picture Intact
Dogs with cardiac disease rarely present in isolation. Concurrent kidney disease affects which medications are safe and at what doses. Multiple cardiac drugs require managing interactions over time. A dog whose records exist across three different clinics and five years of appointments presents a real continuity challenge.
CompanAIn’s Living Memory technology maintains the complete health context across every visit and uploaded record. A cardiologist seeing a dog for the first time has immediate access to years of documented history rather than relying on an owner’s verbal recap. That depth of context supports more precise decisions about when to escalate, when to adjust medication, and when conservative monitoring is still appropriate.
Supporting Home Monitoring Between Appointments
Cardiac disease is managed at home as much as it is in the clinic. Resting respiratory rate logs, exercise tolerance notes, and observations about overnight restlessness are the kind of data points that rarely make it into a formal record without a system designed to capture them.
CompanAIn Assist helps owners document these observations between appointments and arrive at veterinary visits with meaningful data rather than best-guess recollections. When the clinical conversation starts from a documented month of resting respiratory rate trends rather than “he seemed a little off last week,” the decisions that follow are sharper.
Start Building the Cardiac Record That Catches What Single Appointments Miss
Cardiac disease in dogs is won or lost in the margins between appointments. The grades recorded, the rates logged, the observations documented between visits are what give your veterinarian the trajectory they need to act at the right moment. For conditions like MMVD, where a specific treatment window can extend a dog’s healthy life by over a year, that documented history isn’t a nice-to-have. It’s the difference in care quality.
If you’re ready to give your dog that advantage, contact CompanAIn today to start building the cardiac health record they deserve.
Frequently Asked Questions
My dog was just diagnosed with a Grade 2 murmur. How worried should I be?
A Grade 2 murmur in an otherwise healthy dog with no symptoms and no cardiac enlargement on imaging is a finding to monitor rather than an emergency. The key is establishing a documented baseline and committing to regular rechecks so any progression is caught early. In small breeds with known cardiac predispositions, discussing an echocardiogram with your veterinarian is worthwhile even at low grades.
What is the difference between MMVD and DCM?
Myxomatous mitral valve disease affects the valve itself, causing it to leak and place volume stress on the heart gradually. It is most common in small breeds. Dilated cardiomyopathy affects the heart muscle, causing it to weaken and thin. It is most common in large and giant breeds. Both can progress to congestive heart failure but follow different trajectories and require different management.
Does a louder murmur always mean more serious disease?
Not necessarily. Grade reflects loudness and correlates with turbulent blood flow, but a loud murmur doesn’t always indicate more advanced disease than a quieter one. Echocardiography provides far more meaningful information about disease stage and progression than murmur grade alone.
When should pimobendan be started in a dog with MMVD?
According to the EPIC study, dogs with MMVD who show echocardiographic and radiographic evidence of cardiac enlargement benefit significantly from pimobendan before developing congestive heart failure. The decision requires meeting specific diagnostic criteria and should be made in partnership with a veterinary cardiologist.
How does CompanAIn help manage a dog with a known heart murmur?
CompanAIn’s Living Health Timeline organizes every murmur grade, echocardiogram finding, and resting respiratory rate log in chronological order, making year-over-year cardiac trends visible at a glance. Trend Detection alerts flag when values are shifting in ways that warrant attention, and the Vet-Ready AI Summary gives the care team immediate access to the dog’s complete cardiac history at every visit.
